Summit Therapeutics
SMMT
SMMT
223 hedge funds and large institutions have $2.25B invested in Summit Therapeutics in 2026 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 83 increasing their positions, 49 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.06% more ownership
Funds ownership: 15.27% → 15.34% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
15% less call options, than puts
Call options by funds: $39.9M | Put options by funds: $46.7M
Holders
223
Holding in Top 10
3
Calls
$39.9M
Puts
$46.7M
Top Buyers
| 1 | +$45.4M | |
| 2 | +$29.5M | |
| 3 | +$14.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$12.7M |
| 5 |
Morgan Stanley
New York
|
+$11.7M |
Top Sellers
| 1 | -$40.6M | |
| 2 | -$32.9M | |
| 3 | -$20.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$17.7M |
| 5 |
SC
Sculptor Capital
New York
|
-$6.24M |
